GO:0090304 | nucleic acid metabolic process | 61.33% (46/75) | 2.89 | 0.0 | 0.0 |
GO:0016070 | RNA metabolic process | 53.33% (40/75) | 3.16 | 0.0 | 0.0 |
GO:0034660 | ncRNA metabolic process | 40.0% (30/75) | 3.88 | 0.0 | 0.0 |
GO:0006139 | nucleobase-containing compound metabolic process | 61.33% (46/75) | 2.6 | 0.0 | 0.0 |
GO:0006396 | RNA processing | 45.33% (34/75) | 3.39 | 0.0 | 0.0 |
GO:0034470 | ncRNA processing | 36.0% (27/75) | 4.0 | 0.0 | 0.0 |
GO:0034641 | cellular nitrogen compound metabolic process | 64.0% (48/75) | 2.23 | 0.0 | 0.0 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 34.67% (26/75) | 3.74 | 0.0 | 0.0 |
GO:0046483 | heterocycle metabolic process | 61.33% (46/75) | 2.22 | 0.0 | 0.0 |
GO:0016072 | rRNA metabolic process | 26.67% (20/75) | 4.51 | 0.0 | 0.0 |
GO:0006725 | cellular aromatic compound metabolic process | 61.33% (46/75) | 2.02 | 0.0 | 0.0 |
GO:0006364 | rRNA processing | 24.0% (18/75) | 4.5 | 0.0 | 0.0 |
GO:0140098 | catalytic activity, acting on RNA | 28.0% (21/75) | 3.97 | 0.0 | 0.0 |
GO:1901360 | organic cyclic compound metabolic process | 61.33% (46/75) | 1.89 | 0.0 | 0.0 |
GO:0043170 | macromolecule metabolic process | 69.33% (52/75) | 1.63 | 0.0 | 0.0 |
GO:0032991 | protein-containing complex | 50.67% (38/75) | 2.04 | 0.0 | 0.0 |
GO:0006807 | nitrogen compound metabolic process | 69.33% (52/75) | 1.31 | 0.0 | 0.0 |
GO:0043228 | non-membrane-bounded organelle | 40.0% (30/75) | 2.18 | 0.0 | 0.0 |
GO:0043232 | intracellular non-membrane-bounded organelle | 40.0% (30/75) | 2.18 | 0.0 | 0.0 |
GO:0005730 | nucleolus | 26.67% (20/75) | 2.94 | 0.0 | 0.0 |
GO:0003723 | RNA binding | 33.33% (25/75) | 2.36 | 0.0 | 0.0 |
GO:0044238 | primary metabolic process | 69.33% (52/75) | 1.12 | 0.0 | 0.0 |
GO:1990904 | ribonucleoprotein complex | 22.67% (17/75) | 2.99 | 0.0 | 0.0 |
GO:1902494 | catalytic complex | 28.0% (21/75) | 2.53 | 0.0 | 0.0 |
GO:0005654 | nucleoplasm | 26.67% (20/75) | 2.55 | 0.0 | 0.0 |
GO:0006399 | tRNA metabolic process | 14.67% (11/75) | 3.85 | 0.0 | 0.0 |
GO:0044237 | cellular metabolic process | 69.33% (52/75) | 1.03 | 0.0 | 0.0 |
GO:0110165 | cellular anatomical entity | 92.0% (69/75) | 0.61 | 0.0 | 0.0 |
GO:0005575 | cellular_component | 92.0% (69/75) | 0.59 | 0.0 | 0.0 |
GO:0030687 | preribosome, large subunit precursor | 8.0% (6/75) | 5.78 | 0.0 | 0.0 |
GO:0071704 | organic substance metabolic process | 70.67% (53/75) | 0.93 | 0.0 | 0.0 |
GO:0008173 | RNA methyltransferase activity | 8.0% (6/75) | 5.54 | 0.0 | 0.0 |
GO:0005488 | binding | 82.67% (62/75) | 0.72 | 0.0 | 0.0 |
GO:0043229 | intracellular organelle | 73.33% (55/75) | 0.88 | 0.0 | 0.0 |
GO:0043226 | organelle | 73.33% (55/75) | 0.87 | 0.0 | 0.0 |
GO:0009987 | cellular process | 84.0% (63/75) | 0.69 | 0.0 | 0.0 |
GO:0001510 | RNA methylation | 8.0% (6/75) | 5.25 | 0.0 | 1e-06 |
GO:0008152 | metabolic process | 72.0% (54/75) | 0.86 | 0.0 | 1e-06 |
GO:0003676 | nucleic acid binding | 41.33% (31/75) | 1.51 | 0.0 | 1e-06 |
GO:0030684 | preribosome | 9.33% (7/75) | 4.61 | 0.0 | 1e-06 |
GO:0140513 | nuclear protein-containing complex | 21.33% (16/75) | 2.49 | 0.0 | 1e-06 |
GO:0009451 | RNA modification | 14.67% (11/75) | 3.22 | 0.0 | 1e-06 |
GO:0008150 | biological_process | 89.33% (67/75) | 0.54 | 0.0 | 3e-06 |
GO:0004386 | helicase activity | 10.67% (8/75) | 3.87 | 0.0 | 3e-06 |
GO:0140657 | ATP-dependent activity | 16.0% (12/75) | 2.87 | 0.0 | 3e-06 |
GO:1901363 | heterocyclic compound binding | 53.33% (40/75) | 1.11 | 0.0 | 4e-06 |
GO:0008033 | tRNA processing | 10.67% (8/75) | 3.81 | 0.0 | 4e-06 |
GO:0097159 | organic cyclic compound binding | 53.33% (40/75) | 1.1 | 0.0 | 4e-06 |
GO:0003724 | RNA helicase activity | 8.0% (6/75) | 4.59 | 0.0 | 7e-06 |
GO:0003674 | molecular_function | 86.67% (65/75) | 0.54 | 0.0 | 1.1e-05 |
GO:0003899 | DNA-directed 5'-3' RNA polymerase activity | 6.67% (5/75) | 5.14 | 0.0 | 1.1e-05 |
GO:0030488 | tRNA methylation | 5.33% (4/75) | 6.12 | 0.0 | 1.1e-05 |
GO:0090501 | RNA phosphodiester bond hydrolysis | 9.33% (7/75) | 3.95 | 0.0 | 1.2e-05 |
GO:0008186 | ATP-dependent activity, acting on RNA | 8.0% (6/75) | 4.44 | 0.0 | 1.2e-05 |
GO:0140535 | intracellular protein-containing complex | 16.0% (12/75) | 2.62 | 1e-06 | 1.6e-05 |
GO:0097367 | carbohydrate derivative binding | 25.33% (19/75) | 1.88 | 1e-06 | 1.6e-05 |
GO:0032774 | RNA biosynthetic process | 10.67% (8/75) | 3.49 | 1e-06 | 1.7e-05 |
GO:0034062 | 5'-3' RNA polymerase activity | 6.67% (5/75) | 4.96 | 1e-06 | 1.8e-05 |
GO:0097747 | RNA polymerase activity | 6.67% (5/75) | 4.9 | 1e-06 | 2.1e-05 |
GO:0044260 | cellular macromolecule metabolic process | 28.0% (21/75) | 1.68 | 1e-06 | 3.3e-05 |
GO:0000428 | DNA-directed RNA polymerase complex | 6.67% (5/75) | 4.76 | 1e-06 | 3.3e-05 |
GO:0035639 | purine ribonucleoside triphosphate binding | 22.67% (17/75) | 1.95 | 1e-06 | 3.4e-05 |
GO:0062105 | RNA 2'-O-methyltransferase activity | 4.0% (3/75) | 6.91 | 2e-06 | 5e-05 |
GO:0030880 | RNA polymerase complex | 6.67% (5/75) | 4.63 | 2e-06 | 5e-05 |
GO:0006351 | DNA-templated transcription | 8.0% (6/75) | 3.93 | 3e-06 | 7.3e-05 |
GO:0051246 | regulation of protein metabolic process | 21.33% (16/75) | 1.94 | 3e-06 | 7.3e-05 |
GO:0097659 | nucleic acid-templated transcription | 8.0% (6/75) | 3.9 | 3e-06 | 8.1e-05 |
GO:0006400 | tRNA modification | 8.0% (6/75) | 3.9 | 3e-06 | 8.1e-05 |
GO:0016779 | nucleotidyltransferase activity | 8.0% (6/75) | 3.88 | 4e-06 | 8.5e-05 |
GO:0032555 | purine ribonucleotide binding | 22.67% (17/75) | 1.84 | 4e-06 | 8.6e-05 |
GO:0022618 | ribonucleoprotein complex assembly | 9.33% (7/75) | 3.44 | 4e-06 | 9e-05 |
GO:0017076 | purine nucleotide binding | 22.67% (17/75) | 1.83 | 4e-06 | 9e-05 |
GO:0003824 | catalytic activity | 58.67% (44/75) | 0.83 | 4e-06 | 0.000101 |
GO:0005697 | telomerase holoenzyme complex | 4.0% (3/75) | 6.52 | 5e-06 | 0.000102 |
GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic | 6.67% (5/75) | 4.36 | 5e-06 | 0.000107 |
GO:0060255 | regulation of macromolecule metabolic process | 37.33% (28/75) | 1.24 | 5e-06 | 0.000107 |
GO:0098781 | ncRNA transcription | 5.33% (4/75) | 5.17 | 5e-06 | 0.000107 |
GO:0032553 | ribonucleotide binding | 22.67% (17/75) | 1.8 | 5e-06 | 0.000108 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 9.33% (7/75) | 3.38 | 5e-06 | 0.000108 |
GO:0005524 | ATP binding | 20.0% (15/75) | 1.97 | 5e-06 | 0.000108 |
GO:0071826 | ribonucleoprotein complex subunit organization | 9.33% (7/75) | 3.36 | 6e-06 | 0.000115 |
GO:0005736 | RNA polymerase I complex | 4.0% (3/75) | 6.36 | 6e-06 | 0.000131 |
GO:0043933 | protein-containing complex organization | 17.33% (13/75) | 2.12 | 8e-06 | 0.000159 |
GO:0043414 | macromolecule methylation | 9.33% (7/75) | 3.28 | 8e-06 | 0.000161 |
GO:0000967 | rRNA 5'-end processing | 4.0% (3/75) | 6.22 | 9e-06 | 0.000169 |
GO:0034471 | ncRNA 5'-end processing | 4.0% (3/75) | 6.22 | 9e-06 | 0.000169 |
GO:0019222 | regulation of metabolic process | 41.33% (31/75) | 1.1 | 9e-06 | 0.00017 |
GO:0010604 | positive regulation of macromolecule metabolic process | 25.33% (19/75) | 1.6 | 1e-05 | 0.000181 |
GO:0000464 | endonucleolytic cleavage in ITS1 upstream of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.67% (2/75) | 8.44 | 1.1e-05 | 0.000201 |
GO:0080178 | 5-carbamoylmethyl uridine residue modification | 2.67% (2/75) | 8.44 | 1.1e-05 | 0.000201 |
GO:0005515 | protein binding | 62.67% (47/75) | 0.73 | 1.2e-05 | 0.000209 |
GO:0032259 | methylation | 10.67% (8/75) | 2.91 | 1.2e-05 | 0.000211 |
GO:0055029 | nuclear DNA-directed RNA polymerase complex | 5.33% (4/75) | 4.86 | 1.2e-05 | 0.000213 |
GO:0032559 | adenyl ribonucleotide binding | 20.0% (15/75) | 1.86 | 1.2e-05 | 0.00022 |
GO:0030554 | adenyl nucleotide binding | 20.0% (15/75) | 1.85 | 1.3e-05 | 0.000231 |
GO:0005694 | chromosome | 10.67% (8/75) | 2.88 | 1.4e-05 | 0.000236 |
GO:0016787 | hydrolase activity | 28.0% (21/75) | 1.45 | 1.4e-05 | 0.000236 |
GO:0036094 | small molecule binding | 29.33% (22/75) | 1.39 | 1.6e-05 | 0.000272 |
GO:0008175 | tRNA methyltransferase activity | 4.0% (3/75) | 5.91 | 1.7e-05 | 0.000288 |
GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 5.33% (4/75) | 4.69 | 1.9e-05 | 0.00031 |
GO:0002926 | tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation | 2.67% (2/75) | 8.03 | 2.2e-05 | 0.000355 |
GO:0031538 | negative regulation of anthocyanin metabolic process | 2.67% (2/75) | 8.03 | 2.2e-05 | 0.000355 |
GO:0043167 | ion binding | 38.67% (29/75) | 1.09 | 2.4e-05 | 0.000377 |
GO:0006360 | transcription by RNA polymerase I | 4.0% (3/75) | 5.75 | 2.4e-05 | 0.000379 |
GO:0036260 | RNA capping | 4.0% (3/75) | 5.75 | 2.4e-05 | 0.000379 |
GO:0000478 | endonucleolytic cleavage involved in rRNA processing | 5.33% (4/75) | 4.6 | 2.4e-05 | 0.000381 |
GO:0006383 | transcription by RNA polymerase III | 4.0% (3/75) | 5.57 | 3.6e-05 | 0.000553 |
GO:0000166 | nucleotide binding | 26.67% (20/75) | 1.39 | 4.2e-05 | 0.00063 |
GO:1901265 | nucleoside phosphate binding | 26.67% (20/75) | 1.39 | 4.2e-05 | 0.00063 |
GO:0000785 | chromatin | 9.33% (7/75) | 2.91 | 4.2e-05 | 0.000632 |
GO:0008168 | methyltransferase activity | 9.33% (7/75) | 2.91 | 4.3e-05 | 0.000635 |
GO:1990234 | transferase complex | 13.33% (10/75) | 2.27 | 4.1e-05 | 0.00064 |
GO:2000278 | regulation of DNA biosynthetic process | 5.33% (4/75) | 4.37 | 4.4e-05 | 0.000654 |
GO:0000469 | cleavage involved in rRNA processing | 5.33% (4/75) | 4.31 | 5.2e-05 | 0.000754 |
GO:0016741 | transferase activity, transferring one-carbon groups | 9.33% (7/75) | 2.85 | 5.4e-05 | 0.000777 |
GO:0008650 | rRNA (uridine-2'-O-)-methyltransferase activity | 2.67% (2/75) | 7.44 | 5.4e-05 | 0.000779 |
GO:0065003 | protein-containing complex assembly | 14.67% (11/75) | 2.07 | 5.6e-05 | 0.000792 |
GO:0010628 | positive regulation of gene expression | 12.0% (9/75) | 2.35 | 6.7e-05 | 0.000934 |
GO:0016887 | ATP hydrolysis activity | 5.33% (4/75) | 4.22 | 6.6e-05 | 0.000937 |
GO:0009893 | positive regulation of metabolic process | 25.33% (19/75) | 1.39 | 6.8e-05 | 0.00094 |
GO:0010587 | miRNA catabolic process | 2.67% (2/75) | 7.22 | 7.6e-05 | 0.001044 |
GO:0032210 | regulation of telomere maintenance via telomerase | 4.0% (3/75) | 5.12 | 9.1e-05 | 0.001241 |
GO:0010638 | positive regulation of organelle organization | 8.0% (6/75) | 3.04 | 9.3e-05 | 0.001258 |
GO:0002199 | zona pellucida receptor complex | 2.67% (2/75) | 7.03 | 0.000101 | 0.001314 |
GO:0033588 | elongator holoenzyme complex | 2.67% (2/75) | 7.03 | 0.000101 | 0.001314 |
GO:1905323 | telomerase holoenzyme complex assembly | 2.67% (2/75) | 7.03 | 0.000101 | 0.001314 |
GO:0016435 | rRNA (guanine) methyltransferase activity | 2.67% (2/75) | 7.03 | 0.000101 | 0.001314 |
GO:0016436 | rRNA (uridine) methyltransferase activity | 2.67% (2/75) | 7.03 | 0.000101 | 0.001314 |
GO:0000154 | rRNA modification | 4.0% (3/75) | 5.03 | 0.00011 | 0.001424 |
GO:0017111 | ribonucleoside triphosphate phosphatase activity | 8.0% (6/75) | 2.98 | 0.000116 | 0.00149 |
GO:0005819 | spindle | 6.67% (5/75) | 3.36 | 0.000133 | 0.001675 |
GO:0030515 | snoRNA binding | 4.0% (3/75) | 4.94 | 0.000132 | 0.001682 |
GO:0043168 | anion binding | 22.67% (17/75) | 1.42 | 0.000141 | 0.001772 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 10.67% (8/75) | 2.38 | 0.00015 | 0.001863 |
GO:0140101 | catalytic activity, acting on a tRNA | 6.67% (5/75) | 3.28 | 0.000173 | 0.002138 |
GO:0008171 | O-methyltransferase activity | 5.33% (4/75) | 3.84 | 0.000185 | 0.002247 |
GO:0006366 | transcription by RNA polymerase II | 4.0% (3/75) | 4.78 | 0.000184 | 0.002257 |
GO:0010608 | post-transcriptional regulation of gene expression | 10.67% (8/75) | 2.33 | 0.000188 | 0.002266 |
GO:1904356 | regulation of telomere maintenance via telomere lengthening | 4.0% (3/75) | 4.75 | 0.000194 | 0.002326 |
GO:0032549 | ribonucleoside binding | 2.67% (2/75) | 6.57 | 0.000198 | 0.002334 |
GO:0005832 | chaperonin-containing T-complex | 2.67% (2/75) | 6.57 | 0.000198 | 0.002334 |
GO:0006417 | regulation of translation | 9.33% (7/75) | 2.54 | 0.000204 | 0.002396 |
GO:0000966 | RNA 5'-end processing | 4.0% (3/75) | 4.7 | 0.000215 | 0.0025 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 5.33% (4/75) | 3.77 | 0.000221 | 0.002557 |
GO:1904851 | positive regulation of establishment of protein localization to telomere | 2.67% (2/75) | 6.44 | 0.000237 | 0.002684 |
GO:0016423 | tRNA (guanine) methyltransferase activity | 2.67% (2/75) | 6.44 | 0.000237 | 0.002684 |
GO:0006259 | DNA metabolic process | 12.0% (9/75) | 2.1 | 0.00024 | 0.0027 |
GO:0006353 | DNA-templated transcription termination | 4.0% (3/75) | 4.66 | 0.000237 | 0.002718 |
GO:0006281 | DNA repair | 9.33% (7/75) | 2.48 | 0.000269 | 0.003003 |
GO:0005815 | microtubule organizing center | 8.0% (6/75) | 2.75 | 0.000273 | 0.003034 |
GO:0000055 | ribosomal large subunit export from nucleus | 2.67% (2/75) | 6.33 | 0.000279 | 0.003043 |
GO:0070034 | telomerase RNA binding | 2.67% (2/75) | 6.33 | 0.000279 | 0.003043 |
GO:0080090 | regulation of primary metabolic process | 32.0% (24/75) | 1.04 | 0.000282 | 0.003055 |
GO:0017069 | snRNA binding | 4.0% (3/75) | 4.57 | 0.000285 | 0.003059 |
GO:0061695 | transferase complex, transferring phosphorus-containing groups | 6.67% (5/75) | 3.12 | 0.000287 | 0.003061 |
GO:0033044 | regulation of chromosome organization | 6.67% (5/75) | 3.13 | 0.000278 | 0.003066 |
GO:0034248 | regulation of cellular amide metabolic process | 9.33% (7/75) | 2.44 | 0.000305 | 0.003237 |
GO:0050789 | regulation of biological process | 53.33% (40/75) | 0.67 | 0.000326 | 0.003275 |
GO:0070202 | regulation of establishment of protein localization to chromosome | 2.67% (2/75) | 6.22 | 0.000326 | 0.003288 |
GO:0070203 | regulation of establishment of protein localization to telomere | 2.67% (2/75) | 6.22 | 0.000326 | 0.003288 |
GO:1904816 | positive regulation of protein localization to chromosome, telomeric region | 2.67% (2/75) | 6.22 | 0.000326 | 0.003288 |
GO:0000176 | nuclear exosome (RNase complex) | 2.67% (2/75) | 6.22 | 0.000326 | 0.003288 |
GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.67% (2/75) | 6.22 | 0.000326 | 0.003288 |
GO:0031974 | membrane-enclosed lumen | 10.67% (8/75) | 2.22 | 0.000322 | 0.003348 |
GO:0043233 | organelle lumen | 10.67% (8/75) | 2.22 | 0.000322 | 0.003348 |
GO:0070013 | intracellular organelle lumen | 10.67% (8/75) | 2.22 | 0.000322 | 0.003348 |
GO:2000573 | positive regulation of DNA biosynthetic process | 4.0% (3/75) | 4.46 | 0.000353 | 0.003522 |
GO:0001882 | nucleoside binding | 2.67% (2/75) | 6.12 | 0.000375 | 0.0037 |
GO:0000472 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.67% (2/75) | 6.12 | 0.000375 | 0.0037 |
GO:0000049 | tRNA binding | 4.0% (3/75) | 4.4 | 0.000399 | 0.003908 |
GO:1904814 | regulation of protein localization to chromosome, telomeric region | 2.67% (2/75) | 6.03 | 0.000428 | 0.004102 |
GO:0002098 | tRNA wobble uridine modification | 2.67% (2/75) | 6.03 | 0.000428 | 0.004102 |
GO:0048530 | fruit morphogenesis | 2.67% (2/75) | 6.03 | 0.000428 | 0.004102 |
GO:0016462 | pyrophosphatase activity | 8.0% (6/75) | 2.63 | 0.000424 | 0.004126 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 8.0% (6/75) | 2.61 | 0.000455 | 0.004336 |
GO:0010586 | miRNA metabolic process | 2.67% (2/75) | 5.94 | 0.000485 | 0.004564 |
GO:0006402 | mRNA catabolic process | 5.33% (4/75) | 3.47 | 0.000483 | 0.004568 |
GO:0051130 | positive regulation of cellular component organization | 9.33% (7/75) | 2.31 | 0.000534 | 0.004999 |
GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex | 2.67% (2/75) | 5.86 | 0.000545 | 0.005043 |
GO:0001056 | RNA polymerase III activity | 2.67% (2/75) | 5.86 | 0.000545 | 0.005043 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 8.0% (6/75) | 2.56 | 0.000552 | 0.005077 |
GO:0048518 | positive regulation of biological process | 33.33% (25/75) | 0.95 | 0.000557 | 0.005097 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 20.0% (15/75) | 1.36 | 0.000582 | 0.0053 |
GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.67% (2/75) | 5.78 | 0.000608 | 0.005507 |
GO:0140097 | catalytic activity, acting on DNA | 6.67% (5/75) | 2.86 | 0.00064 | 0.005762 |
GO:0042797 | tRNA transcription by RNA polymerase III | 2.67% (2/75) | 5.7 | 0.000675 | 0.006045 |
GO:0009059 | macromolecule biosynthetic process | 13.33% (10/75) | 1.76 | 0.000685 | 0.006103 |
GO:0002097 | tRNA wobble base modification | 2.67% (2/75) | 5.63 | 0.000745 | 0.006567 |
GO:0009304 | tRNA transcription | 2.67% (2/75) | 5.63 | 0.000745 | 0.006567 |
GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity | 6.67% (5/75) | 2.81 | 0.00076 | 0.00663 |
GO:0051171 | regulation of nitrogen compound metabolic process | 29.33% (22/75) | 1.01 | 0.000759 | 0.006654 |
GO:0009303 | rRNA transcription | 2.67% (2/75) | 5.57 | 0.000819 | 0.006993 |
GO:0007339 | binding of sperm to zona pellucida | 2.67% (2/75) | 5.57 | 0.000819 | 0.006993 |
GO:0035036 | sperm-egg recognition | 2.67% (2/75) | 5.57 | 0.000819 | 0.006993 |
GO:0022607 | cellular component assembly | 17.33% (13/75) | 1.45 | 0.000811 | 0.007034 |
GO:0009892 | negative regulation of metabolic process | 20.0% (15/75) | 1.31 | 0.000838 | 0.007123 |
GO:0032204 | regulation of telomere maintenance | 4.0% (3/75) | 4.03 | 0.000853 | 0.007212 |
GO:0031647 | regulation of protein stability | 6.67% (5/75) | 2.76 | 0.000896 | 0.007393 |
GO:0032212 | positive regulation of telomere maintenance via telomerase | 2.67% (2/75) | 5.5 | 0.000895 | 0.007421 |
GO:0035265 | organ growth | 2.67% (2/75) | 5.5 | 0.000895 | 0.007421 |
GO:0032728 | positive regulation of interferon-beta production | 2.67% (2/75) | 5.5 | 0.000895 | 0.007421 |
GO:0000460 | maturation of 5.8S rRNA | 2.67% (2/75) | 5.5 | 0.000895 | 0.007421 |
GO:0008094 | ATP-dependent activity, acting on DNA | 5.33% (4/75) | 3.22 | 0.000913 | 0.007492 |
GO:0000178 | exosome (RNase complex) | 2.67% (2/75) | 5.44 | 0.000976 | 0.007851 |
GO:1905354 | exoribonuclease complex | 2.67% (2/75) | 5.44 | 0.000976 | 0.007851 |
GO:0005666 | RNA polymerase III complex | 2.67% (2/75) | 5.44 | 0.000976 | 0.007851 |
GO:0008266 | poly(U) RNA binding | 4.0% (3/75) | 3.95 | 0.000988 | 0.007874 |
GO:0051247 | positive regulation of protein metabolic process | 10.67% (8/75) | 1.98 | 0.000965 | 0.007884 |
GO:0048522 | positive regulation of cellular process | 28.0% (21/75) | 1.02 | 0.000987 | 0.007908 |
GO:0051656 | establishment of organelle localization | 6.67% (5/75) | 2.71 | 0.001016 | 0.008058 |
GO:0001522 | pseudouridine synthesis | 2.67% (2/75) | 5.38 | 0.001059 | 0.008362 |
GO:0008187 | poly-pyrimidine tract binding | 4.0% (3/75) | 3.9 | 0.001105 | 0.008685 |
GO:0006401 | RNA catabolic process | 5.33% (4/75) | 3.14 | 0.001126 | 0.008803 |
GO:0065007 | biological regulation | 54.67% (41/75) | 0.58 | 0.001133 | 0.008822 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 9.33% (7/75) | 2.12 | 0.001139 | 0.008825 |
GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic | 2.67% (2/75) | 5.33 | 0.001146 | 0.008838 |
GO:0034655 | nucleobase-containing compound catabolic process | 6.67% (5/75) | 2.66 | 0.00121 | 0.009288 |
GO:0009988 | cell-cell recognition | 2.67% (2/75) | 5.27 | 0.001236 | 0.00936 |
GO:1904358 | positive regulation of telomere maintenance via telomere lengthening | 2.67% (2/75) | 5.27 | 0.001236 | 0.00936 |
GO:0032648 | regulation of interferon-beta production | 2.67% (2/75) | 5.27 | 0.001236 | 0.00936 |
GO:2001252 | positive regulation of chromosome organization | 4.0% (3/75) | 3.82 | 0.001297 | 0.009777 |
GO:0071339 | MLL1 complex | 2.67% (2/75) | 5.22 | 0.001329 | 0.009844 |
GO:0016075 | rRNA catabolic process | 2.67% (2/75) | 5.22 | 0.001329 | 0.009844 |
GO:0071027 | nuclear RNA surveillance | 2.67% (2/75) | 5.22 | 0.001329 | 0.009844 |
GO:0031399 | regulation of protein modification process | 10.67% (8/75) | 1.91 | 0.001317 | 0.009884 |
GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.67% (2/75) | 5.17 | 0.001426 | 0.010513 |
GO:0005829 | cytosol | 28.0% (21/75) | 0.97 | 0.001455 | 0.01068 |
GO:0001819 | positive regulation of cytokine production | 4.0% (3/75) | 3.73 | 0.001546 | 0.011295 |
GO:0008649 | rRNA methyltransferase activity | 2.67% (2/75) | 5.07 | 0.001629 | 0.011751 |
GO:0140102 | catalytic activity, acting on a rRNA | 2.67% (2/75) | 5.07 | 0.001629 | 0.011751 |
GO:0071025 | RNA surveillance | 2.67% (2/75) | 5.07 | 0.001629 | 0.011751 |
GO:0003682 | chromatin binding | 8.0% (6/75) | 2.26 | 0.001637 | 0.011758 |
GO:0005665 | RNA polymerase II, core complex | 2.67% (2/75) | 5.03 | 0.001736 | 0.012411 |
GO:0061715 | obsolete miRNA 2'-O-methylation | 1.33% (1/75) | 9.03 | 0.001919 | 0.012585 |
GO:0035072 | ecdysone-mediated induction of salivary gland cell autophagic cell death | 1.33% (1/75) | 9.03 | 0.001919 | 0.012585 |
GO:0035078 | induction of programmed cell death by ecdysone | 1.33% (1/75) | 9.03 | 0.001919 | 0.012585 |
GO:0035081 | induction of programmed cell death by hormones | 1.33% (1/75) | 9.03 | 0.001919 | 0.012585 |
GO:0072684 | mitochondrial tRNA 3'-trailer cleavage, endonucleolytic | 1.33% (1/75) | 9.03 | 0.001919 | 0.012585 |
GO:0106162 | mRNA N-acetyltransferase activity | 1.33% (1/75) | 9.03 | 0.001919 | 0.012585 |
GO:1904812 | rRNA acetylation involved in maturation of SSU-rRNA | 1.33% (1/75) | 9.03 | 0.001919 | 0.012585 |
GO:1990882 | rRNA acetylation | 1.33% (1/75) | 9.03 | 0.001919 | 0.012585 |
GO:1990883 | rRNA cytidine N-acetyltransferase activity | 1.33% (1/75) | 9.03 | 0.001919 | 0.012585 |
GO:0001018 | mitochondrial promoter sequence-specific DNA binding | 1.33% (1/75) | 9.03 | 0.001919 | 0.012585 |
GO:0071601 | sphere organelle | 1.33% (1/75) | 9.03 | 0.001919 | 0.012585 |
GO:0031039 | macronucleus | 1.33% (1/75) | 9.03 | 0.001919 | 0.012585 |
GO:1904868 | telomerase catalytic core complex assembly | 1.33% (1/75) | 9.03 | 0.001919 | 0.012585 |
GO:0043045 | DNA methylation involved in embryo development | 1.33% (1/75) | 9.03 | 0.001919 | 0.012585 |
GO:1900240 | negative regulation of phenotypic switching | 1.33% (1/75) | 9.03 | 0.001919 | 0.012585 |
GO:1901538 | changes to DNA methylation involved in embryo development | 1.33% (1/75) | 9.03 | 0.001919 | 0.012585 |
GO:1905064 | negative regulation of vascular associated smooth muscle cell differentiation | 1.33% (1/75) | 9.03 | 0.001919 | 0.012585 |
GO:1905916 | negative regulation of cell differentiation involved in phenotypic switching | 1.33% (1/75) | 9.03 | 0.001919 | 0.012585 |
GO:1905931 | negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching | 1.33% (1/75) | 9.03 | 0.001919 | 0.012585 |
GO:0000054 | ribosomal subunit export from nucleus | 2.67% (2/75) | 4.94 | 0.001958 | 0.012646 |
GO:0033750 | ribosome localization | 2.67% (2/75) | 4.94 | 0.001958 | 0.012646 |
GO:0031167 | rRNA methylation | 2.67% (2/75) | 4.94 | 0.001958 | 0.012646 |
GO:0031123 | RNA 3'-end processing | 4.0% (3/75) | 3.61 | 0.00195 | 0.01274 |
GO:0006974 | cellular response to DNA damage stimulus | 9.33% (7/75) | 1.98 | 0.002022 | 0.013006 |
GO:0033043 | regulation of organelle organization | 9.33% (7/75) | 1.97 | 0.002047 | 0.013114 |
GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic | 2.67% (2/75) | 4.98 | 0.001845 | 0.013139 |
GO:0051301 | cell division | 8.0% (6/75) | 2.21 | 0.001904 | 0.013501 |
GO:0000175 | 3'-5'-exoribonuclease activity | 2.67% (2/75) | 4.86 | 0.002194 | 0.014004 |
GO:0010629 | negative regulation of gene expression | 9.33% (7/75) | 1.95 | 0.002212 | 0.014068 |
GO:0044665 | MLL1/2 complex | 2.67% (2/75) | 4.82 | 0.002316 | 0.014673 |
GO:0010468 | regulation of gene expression | 25.33% (19/75) | 0.98 | 0.002402 | 0.015157 |
GO:1905634 | regulation of protein localization to chromatin | 2.67% (2/75) | 4.78 | 0.002442 | 0.015352 |
GO:0042273 | ribosomal large subunit biogenesis | 2.67% (2/75) | 4.74 | 0.002571 | 0.016101 |
GO:0016896 | exoribonuclease activity, producing 5'-phosphomonoesters | 2.67% (2/75) | 4.7 | 0.002703 | 0.016864 |
GO:0016071 | mRNA metabolic process | 9.33% (7/75) | 1.9 | 0.002742 | 0.017043 |
GO:0010605 | negative regulation of macromolecule metabolic process | 17.33% (13/75) | 1.25 | 0.002789 | 0.017272 |
GO:0034661 | ncRNA catabolic process | 2.67% (2/75) | 4.67 | 0.002838 | 0.017446 |
GO:0032481 | positive regulation of type I interferon production | 2.67% (2/75) | 4.67 | 0.002838 | 0.017446 |
GO:0051168 | nuclear export | 4.0% (3/75) | 3.39 | 0.002999 | 0.0183 |
GO:0005813 | centrosome | 5.33% (4/75) | 2.75 | 0.002996 | 0.018352 |
GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.67% (2/75) | 4.6 | 0.003117 | 0.018954 |
GO:0031325 | positive regulation of cellular metabolic process | 18.67% (14/75) | 1.17 | 0.003141 | 0.019026 |
GO:0071840 | cellular component organization or biogenesis | 30.67% (23/75) | 0.82 | 0.003419 | 0.020636 |
GO:0016043 | cellular component organization | 29.33% (22/75) | 0.84 | 0.003444 | 0.020714 |
GO:0099080 | supramolecular complex | 9.33% (7/75) | 1.83 | 0.003568 | 0.021304 |
GO:0000373 | Group II intron splicing | 2.67% (2/75) | 4.5 | 0.00356 | 0.021333 |
GO:0006397 | mRNA processing | 6.67% (5/75) | 2.29 | 0.003619 | 0.021532 |
GO:0004532 | exoribonuclease activity | 2.67% (2/75) | 4.47 | 0.003713 | 0.022016 |
GO:0071169 | establishment of protein localization to chromatin | 1.33% (1/75) | 8.03 | 0.003834 | 0.022025 |
GO:0110136 | protein-RNA complex remodeling | 1.33% (1/75) | 8.03 | 0.003834 | 0.022025 |
GO:0031590 | wybutosine metabolic process | 1.33% (1/75) | 8.03 | 0.003834 | 0.022025 |
GO:0031591 | wybutosine biosynthetic process | 1.33% (1/75) | 8.03 | 0.003834 | 0.022025 |
GO:1990275 | preribosome binding | 1.33% (1/75) | 8.03 | 0.003834 | 0.022025 |
GO:1905063 | regulation of vascular associated smooth muscle cell differentiation | 1.33% (1/75) | 8.03 | 0.003834 | 0.022025 |
GO:1905915 | regulation of cell differentiation involved in phenotypic switching | 1.33% (1/75) | 8.03 | 0.003834 | 0.022025 |
GO:1905930 | regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching | 1.33% (1/75) | 8.03 | 0.003834 | 0.022025 |
GO:1901998 | toxin transport | 2.67% (2/75) | 4.44 | 0.00387 | 0.02208 |
GO:0000932 | P-body | 4.0% (3/75) | 3.26 | 0.003858 | 0.022089 |
GO:0044270 | cellular nitrogen compound catabolic process | 6.67% (5/75) | 2.27 | 0.003885 | 0.02209 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 13.33% (10/75) | 1.42 | 0.003901 | 0.022103 |
GO:0051640 | organelle localization | 6.67% (5/75) | 2.27 | 0.003915 | 0.022112 |
GO:0046700 | heterocycle catabolic process | 6.67% (5/75) | 2.26 | 0.003946 | 0.022209 |
GO:0004540 | ribonuclease activity | 4.0% (3/75) | 3.24 | 0.003992 | 0.022393 |
GO:0022613 | ribonucleoprotein complex biogenesis | 4.0% (3/75) | 3.27 | 0.003792 | 0.022405 |
GO:0008013 | beta-catenin binding | 2.67% (2/75) | 4.41 | 0.00403 | 0.022453 |
GO:0015030 | Cajal body | 2.67% (2/75) | 4.41 | 0.00403 | 0.022453 |
GO:0051052 | regulation of DNA metabolic process | 6.67% (5/75) | 2.25 | 0.004101 | 0.022776 |
GO:0006457 | protein folding | 5.33% (4/75) | 2.62 | 0.004165 | 0.023053 |
GO:0000027 | ribosomal large subunit assembly | 2.67% (2/75) | 4.33 | 0.004527 | 0.024973 |
GO:0006378 | mRNA polyadenylation | 2.67% (2/75) | 4.3 | 0.004699 | 0.025834 |
GO:0031981 | nuclear lumen | 4.0% (3/75) | 3.15 | 0.004778 | 0.026185 |
GO:0032479 | regulation of type I interferon production | 2.67% (2/75) | 4.27 | 0.004873 | 0.026619 |
GO:0005739 | mitochondrion | 13.33% (10/75) | 1.38 | 0.004894 | 0.026645 |
GO:0032206 | positive regulation of telomere maintenance | 2.67% (2/75) | 4.24 | 0.005051 | 0.02741 |
GO:0071987 | WD40-repeat domain binding | 2.67% (2/75) | 4.22 | 0.005231 | 0.028298 |
GO:0009553 | embryo sac development | 4.0% (3/75) | 3.09 | 0.005404 | 0.029139 |
GO:0008380 | RNA splicing | 5.33% (4/75) | 2.51 | 0.005504 | 0.029483 |
GO:0001817 | regulation of cytokine production | 4.0% (3/75) | 3.08 | 0.005486 | 0.029483 |
GO:0051306 | mitotic sister chromatid separation | 1.33% (1/75) | 7.44 | 0.005745 | 0.029634 |
GO:0012502 | induction of programmed cell death | 1.33% (1/75) | 7.44 | 0.005745 | 0.029634 |
GO:0051391 | tRNA acetylation | 1.33% (1/75) | 7.44 | 0.005745 | 0.029634 |
GO:1990884 | RNA acetylation | 1.33% (1/75) | 7.44 | 0.005745 | 0.029634 |
GO:2000200 | regulation of ribosomal subunit export from nucleus | 1.33% (1/75) | 7.44 | 0.005745 | 0.029634 |
GO:0006390 | mitochondrial transcription | 1.33% (1/75) | 7.44 | 0.005745 | 0.029634 |
GO:0034245 | mitochondrial DNA-directed RNA polymerase complex | 1.33% (1/75) | 7.44 | 0.005745 | 0.029634 |
GO:0001826 | inner cell mass cell differentiation | 1.33% (1/75) | 7.44 | 0.005745 | 0.029634 |
GO:0006386 | termination of RNA polymerase III transcription | 1.33% (1/75) | 7.44 | 0.005745 | 0.029634 |
GO:2000210 | positive regulation of anoikis | 1.33% (1/75) | 7.44 | 0.005745 | 0.029634 |
GO:0060965 | negative regulation of miRNA-mediated gene silencing | 1.33% (1/75) | 7.44 | 0.005745 | 0.029634 |
GO:0101031 | chaperone complex | 2.67% (2/75) | 4.14 | 0.005791 | 0.029777 |
GO:0009561 | megagametogenesis | 2.67% (2/75) | 4.17 | 0.005601 | 0.029911 |
GO:0051082 | unfolded protein binding | 4.0% (3/75) | 2.97 | 0.006707 | 0.03438 |
GO:0043631 | RNA polyadenylation | 2.67% (2/75) | 4.03 | 0.006781 | 0.034548 |
GO:0000470 | maturation of LSU-rRNA | 2.67% (2/75) | 4.03 | 0.006781 | 0.034548 |
GO:0009057 | macromolecule catabolic process | 10.67% (8/75) | 1.51 | 0.007011 | 0.035611 |
GO:0004518 | nuclease activity | 5.33% (4/75) | 2.4 | 0.007166 | 0.036288 |
GO:0001755 | neural crest cell migration | 1.33% (1/75) | 7.03 | 0.007653 | 0.036534 |
GO:0090497 | mesenchymal cell migration | 1.33% (1/75) | 7.03 | 0.007653 | 0.036534 |
GO:0010589 | leaf proximal/distal pattern formation | 1.33% (1/75) | 7.03 | 0.007653 | 0.036534 |
GO:0030847 | termination of RNA polymerase II transcription, exosome-dependent | 1.33% (1/75) | 7.03 | 0.007653 | 0.036534 |
GO:0071034 | CUT catabolic process | 1.33% (1/75) | 7.03 | 0.007653 | 0.036534 |
GO:0071043 | CUT metabolic process | 1.33% (1/75) | 7.03 | 0.007653 | 0.036534 |
GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity | 1.33% (1/75) | 7.03 | 0.007653 | 0.036534 |
GO:0006529 | asparagine biosynthetic process | 1.33% (1/75) | 7.03 | 0.007653 | 0.036534 |
GO:0070981 | L-asparagine biosynthetic process | 1.33% (1/75) | 7.03 | 0.007653 | 0.036534 |
GO:0070982 | L-asparagine metabolic process | 1.33% (1/75) | 7.03 | 0.007653 | 0.036534 |
GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway | 1.33% (1/75) | 7.03 | 0.007653 | 0.036534 |
GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway | 1.33% (1/75) | 7.03 | 0.007653 | 0.036534 |
GO:0090618 | DNA clamp unloading | 1.33% (1/75) | 7.03 | 0.007653 | 0.036534 |
GO:0014009 | glial cell proliferation | 1.33% (1/75) | 7.03 | 0.007653 | 0.036534 |
GO:0030623 | U5 snRNA binding | 1.33% (1/75) | 7.03 | 0.007653 | 0.036534 |
GO:0045694 | regulation of embryo sac egg cell differentiation | 1.33% (1/75) | 7.03 | 0.007653 | 0.036534 |
GO:2000767 | positive regulation of cytoplasmic translation | 1.33% (1/75) | 7.03 | 0.007653 | 0.036534 |
GO:1900239 | regulation of phenotypic switching | 1.33% (1/75) | 7.03 | 0.007653 | 0.036534 |
GO:0035770 | ribonucleoprotein granule | 5.33% (4/75) | 2.36 | 0.007743 | 0.036855 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 5.33% (4/75) | 2.39 | 0.007355 | 0.037132 |
GO:0031124 | mRNA 3'-end processing | 2.67% (2/75) | 3.92 | 0.007843 | 0.037224 |
GO:0000959 | mitochondrial RNA metabolic process | 5.33% (4/75) | 2.38 | 0.007419 | 0.03734 |
GO:0044183 | protein folding chaperone | 2.67% (2/75) | 3.9 | 0.008063 | 0.038163 |
GO:0008408 | 3'-5' exonuclease activity | 2.67% (2/75) | 3.82 | 0.008974 | 0.042352 |
GO:0051054 | positive regulation of DNA metabolic process | 4.0% (3/75) | 2.81 | 0.00915 | 0.04306 |
GO:0070199 | establishment of protein localization to chromosome | 1.33% (1/75) | 6.7 | 0.009557 | 0.044353 |
GO:0070209 | ASTRA complex | 1.33% (1/75) | 6.7 | 0.009557 | 0.044353 |
GO:0034414 | tRNA 3'-trailer cleavage, endonucleolytic | 1.33% (1/75) | 6.7 | 0.009557 | 0.044353 |
GO:0051151 | negative regulation of smooth muscle cell differentiation | 1.33% (1/75) | 6.7 | 0.009557 | 0.044353 |
GO:0001147 | transcription termination site sequence-specific DNA binding | 1.33% (1/75) | 6.7 | 0.009557 | 0.044353 |
GO:0045727 | positive regulation of translation | 4.0% (3/75) | 2.78 | 0.009601 | 0.04443 |
GO:0043021 | ribonucleoprotein complex binding | 4.0% (3/75) | 2.76 | 0.010065 | 0.046448 |
GO:0031648 | protein destabilization | 2.67% (2/75) | 3.72 | 0.010173 | 0.04682 |
GO:0031331 | positive regulation of cellular catabolic process | 5.33% (4/75) | 2.23 | 0.010592 | 0.048614 |
GO:0060341 | regulation of cellular localization | 6.67% (5/75) | 1.92 | 0.010636 | 0.048682 |
GO:0016796 | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 2.67% (2/75) | 3.69 | 0.010672 | 0.048711 |
GO:0014029 | neural crest formation | 1.33% (1/75) | 6.44 | 0.011458 | 0.049582 |
GO:0042781 | 3'-tRNA processing endoribonuclease activity | 1.33% (1/75) | 6.44 | 0.011458 | 0.049582 |
GO:0061860 | DNA clamp unloader activity | 1.33% (1/75) | 6.44 | 0.011458 | 0.049582 |
GO:0002128 | tRNA nucleoside ribose methylation | 1.33% (1/75) | 6.44 | 0.011458 | 0.049582 |
GO:0106050 | tRNA 2'-O-methyltransferase activity | 1.33% (1/75) | 6.44 | 0.011458 | 0.049582 |
GO:0048254 | snoRNA localization | 1.33% (1/75) | 6.44 | 0.011458 | 0.049582 |
GO:0010424 | DNA methylation on cytosine within a CG sequence | 1.33% (1/75) | 6.44 | 0.011458 | 0.049582 |
GO:0051150 | regulation of smooth muscle cell differentiation | 1.33% (1/75) | 6.44 | 0.011458 | 0.049582 |
GO:1904707 | positive regulation of vascular associated smooth muscle cell proliferation | 1.33% (1/75) | 6.44 | 0.011458 | 0.049582 |
GO:2000811 | negative regulation of anoikis | 1.33% (1/75) | 6.44 | 0.011458 | 0.049582 |
GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.33% (1/75) | 6.44 | 0.011458 | 0.049582 |
GO:0004534 | 5'-3' exoribonuclease activity | 1.33% (1/75) | 6.44 | 0.011458 | 0.049582 |
GO:1900369 | negative regulation of post-transcriptional gene silencing by RNA | 1.33% (1/75) | 6.44 | 0.011458 | 0.049582 |
GO:0007018 | microtubule-based movement | 4.0% (3/75) | 2.69 | 0.011534 | 0.049654 |
GO:0051169 | nuclear transport | 4.0% (3/75) | 2.69 | 0.011534 | 0.049654 |
GO:0032355 | response to estradiol | 2.67% (2/75) | 3.67 | 0.010925 | 0.049731 |
GO:0019843 | rRNA binding | 4.0% (3/75) | 2.68 | 0.011662 | 0.049946 |
GO:0007275 | multicellular organism development | 14.67% (11/75) | 1.12 | 0.011636 | 0.049964 |